Law360
Assessing FDA Pathways For Genome-Edited Plant Foods
March 21, 2024
In February, the U.S. Food and Drug Administration clarified the regulatory pathway for foods produced from genome-edited plants in the form of a final guidance issued by the agency's Center for Food Safety and Applied Nutrition and Center for Veterinary Medicine, titled "Foods Derived from Plants Produced Using Genome Editing." In this article, Sidley analyzes the paths forward that are available.
連絡先
得意分野
Suggested News & Insights
Sidley Healthcare Investment Conference 2026Tuesday, September 22, 2026Swiss MedTech 2026Tuesday, August 25, 2026Recent ESG Developments in EuropeAugust 2026Through the Looking Glass: What WHA79 Reveals About the Future of Global Life SciencesAugust 2026Switzerland Expands Integrity Rules to Medical Devices: Key Compliance Implications for Medtech CompaniesAugust 2026Sidley Represents SlateView Capital in Joint Venture Formation and Acquisition of Meadowbrook at Agoura Hills in Southern CaliforniaAugust 18, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory

